Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3
Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3 is an acid terminated Pharma / Medical Grade homopolymer of DL-lactide with an inherent viscosity midpoint of 1.4 dl/g. It is supplied in the form of white micronized powder.
Product Description
| CAS Number | 26023-30-3 |
| Systematic Name | Poly(2-hydroxy propionic acid), Polylactic acid, Poly DL-lactide, Injectable Poly-Dl-lactic Acid, Ultra-Pure PDLLA. |
| EPA Registry Name | Polylactic acid |
| Substance Type | PLA | DL10014A | Inherent Viscosity : 1.3 - 1.7 dL/g | Acid terminated |DL- Lactide 100% | Mw 130-220 kDa Biodegradable Polymer, Excipient, Non-Active pharmaceutical ingredient, Nanoparticles. |
| Synonym | PLA, Poly(DL-lactide) acid terminated, PDLLA |
| Applications | Drug delivery formulations, ACL Scrow, bioresorbable implants. |
Specification
| Appearance | White powder. |
| Solubility | Soluble in methylene chloride. Insoluble in water. |
| FT NMR (PROTON) | Should comply |
| Viscosity (0.5% in CHCl3 at 30°C) | Between 1.30-1.70 dL/g |
| Residual monomer L-Lactide | ≤ 0.5 % |
| Residual solvent acetone | ≤ 0.1 % |
| Residual solvent toluene | ≤ 890 PPM |
| Total Residual solvent | ≤ 1000 PPM |
| Acid number | 8 - 15 mg KOH/g |
| Heavy metal | ≤ 10 PPM |
| Tin | ≤ 200 PPM |
| Sulphated Ash | ≤ 0.1 % |
| TAMC | ≤ 2000 CFU/g |
| TYMC | ≤ 200 CFU/g |
| Bacterial Endotoxins | ≤ 2000 EU/g |
| Self life | 2 Years |
| See also: | DL-PLA |